KRT6A Is a Biomarker of PAS Progression and Enhances the Invasive Ability of Trophoblast Cells
Cells · 02.07.2026 · 15 (13) · 1204
DOI: 10.3390/cells15131204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 02.07.2026. Verfasst von Zhirong Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Trophoblasts, Keratin-6, Biomarkers. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Scientists Fund (Category C) of the National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding, National Key Research and Development Program of China.
Abstract (Originalsprache)
Placenta Accreta Spectrum (PAS) is a severe obstetric disorder characterized by excessive trophoblast invasion into the uterine myometrium, leading to life-threatening hemorrhage at delivery. While closely monitored, the molecular drivers of its progression remain poorly defined, hindering predictive and therapeutic strategies. Here, we employed longitudinal quantitative proteomics on maternal plasma from five PAS patients across gestation. We identified Keratin 6A (KRT6A) as a key biomarker whose plasma levels increase with PAS progression. Immunohistochemistry confirmed the specific upregulation of KRT6A in trophoblasts at the maternal–fetal interface in PAS. Functional studies demonstrated that KRT6A overexpression significantly enhances the migration and invasion capabilities of trophoblast cell lines in vitro, without affecting proliferation or apoptosis. Integrative bioinformatics analysis linked KRT6A to the activation of the MYC signaling pathway, a known driver of invasiveness. Our data establish KRT6A as a plasma biomarker correlating with PAS severity and a functional regulator of trophoblast invasiveness. These findings suggest a novel mechanism wherein KRT6A-mediated enhancement of trophoblast invasion, potentially via MYC signaling, contributes to PAS pathogenesis. This work provides a potential circulating biomarker for monitoring PAS progression and implicates KRT6A as a candidate therapeutic target for mitigating excessive placental invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.
- Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China.
- Department of Radiation Therapy, Peking University People's Hospital, Beijing 100044, China.
ORCID-Profile: Zhirong Guo
Förderung
- Young Scientists Fund (Category C) of the National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
- National Key Research and Development Program of China
- Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine
Zitieren
APA
Guo, Z., Huang, J., Zheng, W., Dou, R., Yang, X., Yang, H., & Ma, J. (2026). KRT6A Is a Biomarker of PAS Progression and Enhances the Invasive Ability of Trophoblast Cells. Cells, 15(13), 1204. https://doi.org/10.3390/cells15131204
Vancouver
Guo Z, Huang J, Zheng W, Dou R, Yang X, Yang H, et al. KRT6A Is a Biomarker of PAS Progression and Enhances the Invasive Ability of Trophoblast Cells. Cells. 2026;15(13):1204. doi:10.3390/cells15131204
BibTeX
@article{Guo2026,
author = {Guo, Zhirong and Huang, Jiaqi and Zheng, Weiran and Dou, Ruochong and Yang, Xinrui and Yang, Huixia and Ma, Jingmei},
title = {KRT6A Is a Biomarker of PAS Progression and Enhances the Invasive Ability of Trophoblast Cells},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1204},
doi = {10.3390/cells15131204}
}
EUVIMED